https://adisinsight.springer.com/trials/700054974?error=cookies_not_supported&code=9c14798d-8624-4733-bca5-cd09c42648b3
Phase I trial of COL 172, an extended-release formulation of oxymorphone - AdisInsight
This phase I trial will investigate COL 172, an oral, extended-release, abuse resistant formulation of oxymorphone for the treatment of pain.
phase i trialextended release formulationcoloxymorphone